Marbofloxacin
- Marbofloxacin
- 115550-35-1
- Marbocyl
- Zeniquin
- Marbofloxacine
- Create:2005-07-12
- Modify:2025-01-18
- Marbocyl
- Marbocyl FD
- marbofloxacin
- Marbofloxacin
- 115550-35-1
- Marbocyl
- Zeniquin
- Marbofloxacine
- Marbofloxacino
- Marbofloxacinum
- Marbofloxacine [INN-French]
- Marbofloxacinum [INN-Latin]
- Marbofloxacino [INN-Spanish]
- UNII-8X09WU898T
- CCRIS 8212
- DTXSID4046600
- 8X09WU898T
- MFCD00864820
- 7H-Pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
- 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid
- DTXCID2026600
- RO 09-1168
- 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid
- NCGC00166310-01
- Marbofloxacine (INN-French)
- Marbofloxacinum (INN-Latin)
- 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
- 7H-Pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
- 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid
- 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid
- Marbofloxacino (INN-Spanish)
- MARBOFLOXACIN (MART.)
- MARBOFLOXACIN [MART.]
- Marbofloxacin [INN]
- 9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid
- CAS-115550-35-1
- Marbofloxacin [INN:BAN]
- Marboquin
- FluroFlox
- Marbofloxacin?
- 9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid; Aurizon; Marbocyl; Marbofloxacin; Zeniquin
- DELAQUIN
- Marbofloxacin (Standard)
- Marbofloxacin (USP/INN)
- MARBOFLOXACIN [MI]
- Oprea1_079403
- Marbofloxacin Chewable Tablets
- SCHEMBL134860
- CHEMBL478120
- CHEBI:94723
- HY-B0126R
- EX-A015
- MARBOFLOXACIN [GREEN BOOK]
- HY-B0126
- RKL10084
- Marbofloxacin for peak identification
- Tox21_112406
- s1464
- AKOS015853291
- Tox21_112406_1
- BCP9000896
- CCG-229989
- CS-1892
- DB11426
- GS-3323
- NCGC00166310-02
- NCGC00166310-03
- 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-piperazino)-7-oxo-7H-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic acid
- AC-24289
- BM164656
- DB-041275
- M2240
- NS00010545
- D08156
- H10130
- AB01566820_01
- Marbofloxacin, VETRANAL(TM), analytical standard
- Q909359
- SR-01000772975
- Q-201338
- SR-01000772975-2
- BRD-K71926323-001-12-0
- BRD-K71926323-001-13-8
- BRD-K71926323-001-14-6
- Marbofloxacin, European Pharmacopoeia (EP) Reference Standard
- Marbofloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard
- 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2- diazatricyclo[7.3.1.0^5,13^]trideca-5,7,9(13),11-tetraene-11-carboxylic acid
- 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13),11-tetraene-11-carboxylic acid
- 7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
- 7H-1,3,4-Oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
- 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl -1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid
- 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol(3,2,1-ij)(4,2,1)benzoxadiazin-6 carboxylic acid
- 9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)- 7-oxo-7H-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic acid
198.5 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]
190.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]
191.21 Ų [M+H]+
195.77 Ų [M+Na]+
72.0807 100
70.0651 20.90
205.0409 8.39
164.0506 3.87
204.0456 3.50
72.0807 100
70.0651 29.67
122.0401 7.15
164.0506 6.03
205.0404 5.84
363.1499 999
72.0808 944
320.1064 703
364.1532 262
277.0634 233
363.146 999
320.1041 130
72.0807 38
276.1142 22
345.1355 5
P273, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 73 reports by companies from 7 notifications to the ECHA C&L Inventory.
Reported as not meeting GHS hazard criteria per 1 of 73 reports by companies. For more detailed information, please visit ECHA C&L website.
There are 6 notifications provided by 72 of 73 reports by companies with hazard statement code(s).
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=BPFYOAJNDMUVBL-UHFFFAOYSA-N
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/
- ChemIDplusMarbofloxacin [INN:BAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0115550351ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useMarbofloxacinhttps://www.drugbank.ca/drugs/DB11426
- EPA DSSToxMarbofloxacinhttps://comptox.epa.gov/dashboard/DTXSID4046600CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]-benzoxadiazine-6-caboxylic acidhttps://echa.europa.eu/substance-information/-/substanceinfo/100.168.1819-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]-benzoxadiazine-6-caboxylic acid (EC: 640-416-5)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/173050
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/MarbofloxacinNORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- ChEBI
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceMARBOFLOXACINhttps://platform.opentargets.org/drug/CHEMBL478120
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jspmarbofloxacinhttps://ctdbase.org/detail.go?type=chem&acc=C080260
- Crystallography Open Database (COD)LICENSEAll data in the COD and the database itself are dedicated to the public domain and licensed under the CC0 License. Users of the data should acknowledge the original authors of the structural data.https://creativecommons.org/publicdomain/zero/1.0/
- The Cambridge Structural Database
- DailyMed
- FDA Approved Animal Drug Products (Green Book)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- Human Metabolome Database (HMDB)LICENSEHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.http://www.hmdb.ca/citingMarbofloxacinhttp://www.hmdb.ca/metabolites/HMDB0254332HMDB0254332_msms_2234166https://hmdb.ca/metabolites/HMDB0254332#spectra
- NIST Mass Spectrometry Data CenterLICENSEData covered by the Standard Reference Data Act of 1968 as amended.https://www.nist.gov/srd/public-lawMarbofloxacinhttp://www.nist.gov/srd/nist1a.cfm
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAntiinfectiveshttp://www.genome.jp/kegg-bin/get_htext?br08307.kegAnimal drugs in Japanhttp://www.genome.jp/kegg-bin/get_htext?br08331.keg
- MassBank Europe
- MassBank of North America (MoNA)LICENSEThe content of the MoNA database is licensed under CC BY 4.0.https://mona.fiehnlab.ucdavis.edu/documentation/license
- Metabolomics Workbench
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlmarbofloxacinhttps://rxnav.nlm.nih.gov/id/rxnorm/69256
- SpectraBaseMarbofloxacinhttps://spectrabase.com/spectrum/BZjdOBdSXMrMarbofloxacinhttps://spectrabase.com/spectrum/K3kmrMUkY22
- Springer Nature
- Wikidatamarbofloxacinhttps://www.wikidata.org/wiki/Q909359
- WikipediaRifapentinehttps://en.wikipedia.org/wiki/RifapentineMarbofloxacinhttps://en.wikipedia.org/wiki/Marbofloxacin
- PubChemPFAS and Fluorinated Compounds in PubChemhttps://gitlab.com/uniluxembourg/lcsb/eci/pubchem-docs/-/raw/main/pfas-tree/PFAS_Tree.pdf?inline=false
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlmarbofloxacinhttps://www.ncbi.nlm.nih.gov/mesh/67080260Anti-Bacterial Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000900
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 389138155https://pubchem.ncbi.nlm.nih.gov/substance/389138155